Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort

82Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

PURPOSELung cancer screening saves lives, but implementation is challenging. We evaluated two approaches to early lung cancer detection - low-dose computed tomography screening (LDCT) and program-based management of incidentally detected lung nodules.METHODSA prospective observational study enrolled patients in the early detection programs. For context, we compared them with patients managed in a Multidisciplinary Care Program. We compared clinical stage distribution, surgical resection rates, 3- and 5-year survival rates, and eligibility for LDCT screening of patients diagnosed with lung cancer.RESULTSFrom 2015 to May 2021, 22,886 patients were enrolled: 5,659 in LDCT, 15,461 in Lung Nodule, and 1,766 in Multidisciplinary Care. Of 150, 698, and 1,010 patients diagnosed with lung cancer in the respective programs, 61%, 60%, and 44% were diagnosed at clinical stage I or II, whereas 19%, 20%, and 29% were stage IV (P =.0005); 47%, 42%, and 32% had curative-intent surgery (P

Cite

CITATION STYLE

APA

Osarogiagbon, R. U., Liao, W., Faris, N. R., Meadows-Taylor, M., Fehnel, C., Lane, J., … Smeltzer, M. P. (2022). Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort. Journal of Clinical Oncology, 40(19), 2094–2105. https://doi.org/10.1200/JCO.21.02496

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free